Pharmaceuticals, Biotechnology and Life Sciences
CMP-001, a TLR9 Agonist, to be Evaluated in Combination with BAVENCIO®; with or without Utomilumab, a 4-1BB Agonist, and PF-04518600,…
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2019 sales…
Industry veteran brings extensive experience leading biotech companies through periods of growth WALTHAM, Mass.–(BUSINESS WIRE)–Dyne Therapeutics, a biotechnology company pioneering…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#oncology—Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, today announced the appointment…
European Union’s Horizon 2020 Program Funding Underwrites Second-Generation Zika Vaccine Candidate Development VIENNA–(BUSINESS WIRE)–Themis Bioscience announced today the initiation of…
Azelis, a leading distributor of specialty chemicals and food ingredients, will acquire Orkila, the top specialty chemicals and food ingredients distributor throughout Africa and the Middle East.
The market will accelerate at a CAGR of 9.82% between 2019-2023 LONDON–(BUSINESS WIRE)–#ContainersandPackaging–The report, parenteral product packaging market 2019-2023, has…
TOKYO & ZURICH–(BUSINESS WIRE)–Numab Therapeutics AG (Numab) today announced the initiation of a partnership with Eisai, Co., Ltd (Eisai), under…
Dr. Juliane Bernholz has joined as Chief Operating Officer Ms. Kristie Bass has joined as VP Clinical Operations BUNNIK,…
Swedish Orphan Biovitrum (Sobi) said Monday it will Dova Pharmaceuticals for an upfront payment of $27.50 per share in cash and, one non-tradeable Contingent Value Right (CVR), with an additional $1.50 for shareholders upon approval of Doptelet for use in Chemotherapy-Induced Thrombocytopenia (CIT) by the US Food and Drug Administration (FDA).